Skip to main content
Erschienen in: Inflammation 1/2023

20.10.2022 | Original Article

Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease

verfasst von: Lu Cheng, Yanhong Li, Yubin Luo, Yu Zhou, Ji Wen, Yinlan Wu, Xiuping Liang, Tong Wu, Chunyu Tan, Yi Liu

Erschienen in: Inflammation | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Interstitial lung disease (ILD) is a highly fatal manifestation of idiopathic inflammatory myopathies (IIMs). Th cells play important roles in the initiation of ILD. Here, we investigated the clinical significance of peripheral blood Th cells in IIMs-ILD patients. Eleven healthy controls (HC) and 53 patients diagnosed with IIMs were included, including 30 with ILD (IIMs-ILD) and 23 without ILD (IIMs-non-ILD). Circulating Th1, Th2, Th17, and Treg cells were examined by flow cytometry, and their correlation with clinical and laboratory findings was analyzed by Spearman’s correlation and logistic regression. The proportion of Th1 cells decreased and Th2 cells increased in IIMs-ILD compared with IIMs-non-ILD (median (quartile): 2.99 (1.59–5.39) vs. 6.91 (3.48–10.04), p < 0.001; 2.67 (1.79–4.67) vs. 1.62 (0.85–2.66), p = 0.006) and correlated with disease activity. The Th1-cell proportion decreased in anti-MDA5 antibody-positive patients, while the Th2 cell proportion increased in patients with nonspecific interstitial pneumonia compared with IIMs-non-ILD (2.66 (1.06–4.35) vs. 6.91 (3.48–10.04), p = 0.002; 3.09 (2.03–5.72) vs. 1.62 (0.85–2.66), p = 0.016). Univariate analysis showed that a lower Th1 proportion, higher Th2 proportion increased, lower CK level, positivity for ARS, or anti-Ro52 antibodies (OR = 0.7122; OR = 1.679; OR = 0.9993; OR = 9.188; and OR = 6.161, respectively) were associated with the occurrence of ILD in IIMs patients. Decreased Th1 cells and elevated Th2 cells in peripheral blood may be involved in the pathogenesis of ILD in IIMs patients and have different effects on different serological and imaging subtypes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Rothwell, S., R.G. Cooper, I.E. Lundberg, F.W. Miller, P.K. Gregersen, J. Bowes, J. Vencovsky, K. Danko, V. Limaye, A. Selva-O'Callaghan, M.G. Hanna, P.M. Machado, L.M. Pachman, A.M. Reed, L.G. Rider, J. Cobb, H. Platt, Ø. Molberg, O. Benveniste, P. Mathiesen, T. Radstake, A. Doria, J. De Bleecker, B. De Paepe, B. Maurer, W.E. Ollier, L. Padyukov, T.P. O'Hanlon, A. Lee, C.I. Amos, C. Gieger, T. Meitinger, J. Winkelmann, L.R. Wedderburn, H. Chinoy, J.A. Lamb. 2016. Myositis Genetics Consortium. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Annals of the Rheumatic Diseases 75(8):1558–66. https://doi.org/10.1136/annrheumdis-2015-20811 Rothwell, S., R.G. Cooper, I.E. Lundberg, F.W. Miller, P.K. Gregersen, J. Bowes, J. Vencovsky, K. Danko, V. Limaye, A. Selva-O'Callaghan, M.G. Hanna, P.M. Machado, L.M. Pachman, A.M. Reed, L.G. Rider, J. Cobb, H. Platt, Ø. Molberg, O. Benveniste, P. Mathiesen, T. Radstake, A. Doria, J. De Bleecker, B. De Paepe, B. Maurer, W.E. Ollier, L. Padyukov, T.P. O'Hanlon, A. Lee, C.I. Amos, C. Gieger, T. Meitinger, J. Winkelmann, L.R. Wedderburn, H. Chinoy, J.A. Lamb. 2016. Myositis Genetics Consortium. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Annals of the Rheumatic Diseases 75(8):1558–66. https://​doi.​org/​10.​1136/​annrheumdis-2015-20811
10.
Zurück zum Zitat Rider, L.G., V.P. Werth, A.M. Huber, et al. 2011. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care and Research (Hoboken) 63 Suppl 11(0 11):S118–57. https://doi.org/10.1002/acr.20532 Rider, L.G., V.P. Werth, A.M. Huber, et al. 2011. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care and Research (Hoboken) 63 Suppl 11(0 11):S118–57. https://​doi.​org/​10.​1002/​acr.​20532
13.
Zurück zum Zitat Travis, W.D., U. Costabel, D.M. Hansell, et al. 2013. ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine 188(6):733–48. https://doi.org/10.1164/rccm.201308-1483ST Travis, W.D., U. Costabel, D.M. Hansell, et al. 2013. ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine 188(6):733–48. https://​doi.​org/​10.​1164/​rccm.​201308-1483ST
18.
Zurück zum Zitat Gono, T., H. Kaneko, Y. Kawaguchi, M. Hanaoka, S. Kataoka, M. Kuwana, K. Takagi, H. Ichida, Y. Katsumata, Y. Ota, H. Kawasumi, and H. Yamanaka. 2014. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology (Oxford) 53 (12): 2196–2203. https://doi.org/10.1093/rheumatology/keu258.CrossRefPubMed Gono, T., H. Kaneko, Y. Kawaguchi, M. Hanaoka, S. Kataoka, M. Kuwana, K. Takagi, H. Ichida, Y. Katsumata, Y. Ota, H. Kawasumi, and H. Yamanaka. 2014. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. Rheumatology (Oxford) 53 (12): 2196–2203. https://​doi.​org/​10.​1093/​rheumatology/​keu258.CrossRefPubMed
20.
Zurück zum Zitat Frantz, C., A. Cauvet, A. Durand, V. Gonzalez, R. Pierre, M. Do Cruzeiro, K. Bailly, M. Andrieu, C. Orvain, J. Avouac, M. Ottaviani, R. Thuillet, L. Tu, C. Guignabert, B. Lucas, C. Auffray, and Y. Allanore. 2022. IL-2-related regulatory CD4 T-cell deficiency leads to the development of lung fibrosis and vascular remodeling. Arthritis & Rhematology. https://doi.org/10.1002/art.42111.CrossRef Frantz, C., A. Cauvet, A. Durand, V. Gonzalez, R. Pierre, M. Do Cruzeiro, K. Bailly, M. Andrieu, C. Orvain, J. Avouac, M. Ottaviani, R. Thuillet, L. Tu, C. Guignabert, B. Lucas, C. Auffray, and Y. Allanore. 2022. IL-2-related regulatory CD4 T-cell deficiency leads to the development of lung fibrosis and vascular remodeling. Arthritis & Rhematology. https://​doi.​org/​10.​1002/​art.​42111.CrossRef
24.
Zurück zum Zitat Shen, H., L. Xia, and J. Lu. 2013. Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: A pilot study. Indian Journal of Medical Research 138 (6): 919–921.PubMedPubMedCentral Shen, H., L. Xia, and J. Lu. 2013. Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: A pilot study. Indian Journal of Medical Research 138 (6): 919–921.PubMedPubMedCentral
25.
29.
31.
Zurück zum Zitat Marie, I., S. Josse, O. Decaux, S. Dominique, E. Diot, C. Landron, P. Roblot, S. Jouneau, P.Y. Hatron, K.P. Tiev, O. Vittecoq, D. Noel, L. Mouthon, J.F. Menard, and F. Jouen. 2012. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmunity Reviews 11 (10): 739–745. https://doi.org/10.1016/j.autrev.2012.01.006).CrossRefPubMed Marie, I., S. Josse, O. Decaux, S. Dominique, E. Diot, C. Landron, P. Roblot, S. Jouneau, P.Y. Hatron, K.P. Tiev, O. Vittecoq, D. Noel, L. Mouthon, J.F. Menard, and F. Jouen. 2012. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmunity Reviews 11 (10): 739–745. https://​doi.​org/​10.​1016/​j.​autrev.​2012.​01.​006).CrossRefPubMed
32.
Zurück zum Zitat Ferreira, B.S.A., B.M.D. Cunha, L.A. Moreira, M.F.S.E. Fonseca, and E.B.U. Cavalcante. 2022. Comments: Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (São Paulo, Brazil) 23 (77): 100077. https://doi.org/10.1016/j.clinsp.2022.100077.CrossRef Ferreira, B.S.A., B.M.D. Cunha, L.A. Moreira, M.F.S.E. Fonseca, and E.B.U. Cavalcante. 2022. Comments: Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (São Paulo, Brazil) 23 (77): 100077. https://​doi.​org/​10.​1016/​j.​clinsp.​2022.​100077.CrossRef
Metadaten
Titel
Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease
verfasst von
Lu Cheng
Yanhong Li
Yubin Luo
Yu Zhou
Ji Wen
Yinlan Wu
Xiuping Liang
Tong Wu
Chunyu Tan
Yi Liu
Publikationsdatum
20.10.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01747-5

Weitere Artikel der Ausgabe 1/2023

Inflammation 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.